Branson Pharma develop a biomolecule capable of effectively treating the most challenging gynaecology conditions - endometritis, endometriosis. The cure.
Branson Pharma develop a bio molecule that demonstrates a high efficacy and speed to eliminate a range of infections related to gynecologic conditions in uterus and fallopian tubes (endometritis, endometriosis, adenomyosis, etc.), The molecule specifically targets infected cells only, dissolving dead and infected tissue by breaking any infection down into basic amino acids and removing them, Early tests demonstrated a significant efficacy closer to 100% treatment rate, At Branson Pharma we believe the final product can be called a cure, Cost effective to produce, We are now open to discuss co-investment options and to decide on locating future manufacuring in the EU